| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $28.7M | — | +5.4% |
| SG&A Expense | $9.1M | — | -13.6% |
| Operating Income | -$37.9M | — | +17.0% |
| Pre-tax Income | -$35.2M | — | +27.0% |
| Income Tax | $120K | — | — |
| Net Income | -$35.4M | — | +26.8% |
| EPS (Basic) | -$0.50 | — | +25.4% |
| EPS (Diluted) | -$0.50 | — | +25.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.9M | -11.3% | -23.8% |
| Current Assets | $218.1M | -13.9% | -36.4% |
| Total Assets | $253.1M | -12.4% | -34.1% |
| Current Liabilities | $35.2M | -3.6% | -28.7% |
| Total Liabilities | $70.4M | -3.3% | -20.6% |
| Stockholders' Equity | $182.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.0M | — | -1.0% |
| Capital Expenditures | $34K | — | — |
| Investing Cash Flow | $30.0M | — | -25.8% |
| Financing Cash Flow | -$1.1M | — | -694.2% |
| Free Cash Flow | -$33.0M | — | -1.1% |
| -38.2% |